Clinical Trial Detail

NCT ID NCT03312114
Title Anti—PD-L1 and SAbR for Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Avelumab

Age Groups: adult senior

No variant requirements are available.